SUBSCRIBE
SUBSCRIBE
News   Business

Biota Holdings Limited, GlaxoSmithKline Release: UK Government Orders 10.6 Million Courses of Relenza, Royalty Income of Up to $18 Million After Completion of Contract

January 30, 2009 | 
1 min read
Melbourne, Jan 30, 2009 (ABN Newswire) - Biota Holdings Limited (ASX:BTA)(PINK:BTAHY) today announced that GlaxoSmithKline (LON:GSK) has been awarded a significant contract by the UK Department of Health for 10.6 million treatment courses of RelenzaTM (zanamivir).
Alliances Asia Australia
GlaxoSmithKline
MORE ON THIS TOPIC
Two human hands with a gesture of a handshake agreement and dollar banknotes with dollar signs on a colored background. Concept of business contract or agreement. Collage art
Mergers & acquisitions
Chiesi, Arbor Weave $2.1B Rare Disease Pact
October 6, 2025
 · 
1 min read
 · 
Tristan Manalac
Group of blue paper boats following on red on yellow background, mass manipulation
Mergers & acquisitions
How Akero’s MASH Success Drove Roche’s $3.5B Takeout of 89bio
October 2, 2025
 · 
3 min read
 · 
Annalee Armstrong
Hand shake icon on wooden cube block which connection with human icon for business deal and agreement concept.
Mergers & acquisitions
Halozyme’s $900M Elektrofi Buyout Brings Two Big Pharma Partners Together
October 2, 2025
 · 
2 min read
 · 
Tristan Manalac
Success Way and freedom. Business woman walking to the exit through an open door.
Cell therapy
Takeda Exits Cell Therapy Amid Strategic Pivot, Dealing Blow to Once Promising Modality
October 2, 2025
 · 
2 min read
 · 
Tristan Manalac